70NANB21H086
Cooperative Agreement
Overview
Grant Description
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Awardee
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Newark,
Delaware
19716-0099
United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Analysis Notes
Amendment Since initial award the total obligations have increased 929% from $8,900,000 to $91,600,000.
University Of Delaware was awarded
Advancing Biopharmaceutical Manufacturing with NIIMBL
Cooperative Agreement 70NANB21H086
worth $45,800,000
from the National Institute of Standards and Technology in July 2021 with work to be completed primarily in Newark Delaware United States.
The grant
has a duration of 6 years and
was awarded through assistance program 11.619 Arrangements for Interdisciplinary Research Infrastructure.
$45,800,000 (50.0%) of this Cooperative Agreement was funded by non-federal sources.
Status
(Ongoing)
Last Modified 7/3/24
Period of Performance
7/1/21
Start Date
6/30/27
End Date
Funding Split
$45.8M
Federal Obligation
$45.8M
Non-Federal Obligation
$91.6M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for 70NANB21H086
Transaction History
Modifications to 70NANB21H086
Additional Detail
Award ID FAIN
70NANB21H086
SAI Number
70NANB21H086_7
Award ID URI
EXE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
1333ND DEPT OF COMMERCE NIST
Funding Office
1333ND DEPT OF COMMERCE NIST
Awardee UEI
T72NHKM259N3
Awardee CAGE
015X1
Performance District
DE-00
Senators
Thomas Carper
Christopher Coons
Christopher Coons
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Industrial Technology Services, National Institute of Standards and Technology, Commerce (013-0525) | Other advancement of commerce | Grants, subsidies, and contributions (41.0) | $22,900,000 | 100% |
Modified: 7/3/24